This inventor holds 1 USPTO granted patent. Top assignees: Baotou Dongbao Bio Tech Co Ltd., Chinese Academy of Sciences, Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Innovations of Jianing Wang in Cancer Research
Introduction
Jianing Wang is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of cancer research through his innovative work on collagen active peptides. His research focuses on developing methods that can potentially aid in cancer treatment.
Latest Patents
Jianing Wang holds a patent for "Techniques of preparing collagen active peptides." This patent describes a method of preparing collagen active peptides that exhibit antiproliferative activity against various cancer cells. The peptides are obtained through the hydrolysis of papain and trypsin, followed by a specific purifying process. Notably, these collagen active peptides have shown effectiveness against ovarian carcinoma cells, including SKOV3, OVCAR3, 436, and SRO82, as well as prostate cancer cells such as PC3, LnCAPC1, and LnCAPC2. He has 1 patent to his name.
Career Highlights
Throughout his career, Jianing Wang has worked with Baotou Dongbao Bio Tech Co Ltd., where he has applied his expertise in biochemistry and molecular biology to advance cancer research. His innovative approaches have garnered attention in the scientific community.
Collaborations
Jianing Wang has collaborated with notable colleagues, including Yanchuan Guo and Bing Zhang, who have contributed to his research endeavors. Their combined efforts have enhanced the understanding of collagen active peptides and their potential applications in cancer therapy.
Conclusion
Jianing Wang's work exemplifies the intersection of innovation and cancer research. His patented techniques for preparing collagen active peptides represent a promising avenue for future cancer treatments. His contributions continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile